Investigation of vaginal microbiota in sexually active women using hormonal contraceptives in Pakistan
Previous studies report association of contraceptives with moderate increase in urinary tract infection among sexually active premenopausal women. The aim of our study was to find out whether the use of hormonal contraceptives has any effect on microbiota of the vagina in the contraceptives users in Khairpur Sindh Pakistan.
A prospective study in woman population of Khairpur Sindh Pakistan aged 20–30 years and 31–40 years, using Hormonal contraceptives was carried out. High vaginal swab samples (n = 100) were collected from the test populations as well as control group (n = 100) and investigated for vaginal microbial flora using standard microbiological and biochemical techniques.
Vaginal swabs culturing from hormonal contraceptives users in the age group 20–30 years showed statistically insignificant Candida sp (10% samples), and statistically significant (p < 0.05) Staphylococcus saprophyticus. (18% samples), Streptococcus agalactiae (23% samples), Escherichia coli (28% samples) and Lactobacillus fermentum (32% samples). In the age group 31–40 years, statistically significant percentage of samples (p < 0.05) showed Lactobacillus fermentum (28%), Candida sp (24%), and E. coli, (24%) where statistically insignificant samples showed Staphylococcus saprophyticus (13%) and Streptococcus agalactiae (11%).
The use of hormonal contraceptives alters the normal microbiota of vagina in women according to the age. Lactobacillus fermentum appeared as the predominant species followed by E. coli among the age group of 20–30 years and, Lactobacillus fermentum, Candida sp and E. coli as predominant among women of age group 31–40 years when compared to corresponding control groups. An inverse relationship between E. coli and Lactobacillus fermentum was observed in the women aged 20–30 years.
- Townsend MK, Curhan GC, Resnick NM, Grodstein F: Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol 2009,181(5):2170–2175. CrossRef
- Steinauer JE, Waetjen LE, Vittinghoff E, Subak LL, Hulley SB, Grady D: Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol 2005, 106:940. CrossRef
- Foxman B: Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002,113(1A):5. CrossRef
- David AG, Kenneth FS: Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception 2011, 83:5–9. CrossRef
- Population reference bureau. 2011. http://www.pwdsindh.gov.pk
- Gupta K, Hillier SL, Hooton TM, Roberts PL, Stamm WE: Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infect Dis 2000, 181:595–601. CrossRef
- Bauer AW, Kirby WM, Sherris JC, Turck M: Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 1966, 36:493–496.
- Balows A, Hauser WJ, Herrmann KL, Isenberg HD, Shadomy HJ: Manual of clinical microbiology. 5th edition. Washington, DC: American Society for Microbiology; 1991.
- Cheesbrough M: District Laboratory Practice in Tropical Countries vol. 2. New York: Cambridge University Press; 2006:62–70. CrossRef
- Vickers AA, Chopra I, O’ Neil AJ: Intrinsic Novobiocin resistance in Staphylococcus. Antimicrob Agents Chemother 2007, 5:4484–4485. CrossRef
- Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Stergachis A, Stamm WE: A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996, 335:468–474. CrossRef
- Acton S, O’Meara YM: Urinary tract infection and contraceptive method. Irish Med J 1997,90(5):176. [Pmid:9345824]
- Dienye PO, Gbeneol PK: Contraception as a risk factor for urinary tract infection in Port Harcourt, Nigeria: a case control study. Afr J Prim Health Care Fam Med 2011,3(1):1–4. CrossRef
- Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al.: Oral use of Lactobacillus rhamnosus GR-1 and L . fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003, 35:131–134. CrossRef
- Pavlova SI, Kilic AO, Kilic SS, So JS, Nader-Macias ME, Simoes JA, et al.: Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J Appl Microbiol 2002, 92:451–459. CrossRef
- Peddie BA, Bishop V, Bailey RR, McGill HR: Relationship between contraceptive method and vaginal flora. Aust N Z J Obstet Gynaecol 1984,24(3):217–218. CrossRef
- Barbes C, Boris S: Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS 1999, 13:747–751. CrossRef
- Johnson JV, Grubb GS, Constantine GD: Endometrial histology following 1 year of continuous daily regimen of levonorgestrel 90 μg/ethinyl estradiol 20 μg. Contraception 2007, 75:23–26. CrossRef
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2490/12/22/prepub
- Investigation of vaginal microbiota in sexually active women using hormonal contraceptives in Pakistan
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Online Date
- August 2012
- Online ISSN
- BioMed Central
- Additional Links